Corus Pharma - Ownership and Business Overview

Life ScienceCompany

Corus Pharma Ownership

Who owns Corus Pharma?

Corus Pharma is owned by Gilead Sciences. It was acquired on August 11, 2006.

Corus Pharma Business Overview

Where is Corus Pharma headquartered?

Corus Pharma is headquartered in Seattle, Washington.

How many employees does Corus Pharma have?

Corus Pharma has 86 employees.

What sector is Corus Pharma in?

Corus Pharma is a life science company.

When was Corus Pharma founded?

Corus Pharma was founded in 2001.

Life Science M&A Summary in 2006

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.

Join Mergr to view all 120 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 98 by strategics.

Corus Pharma, Inc.

2025 1st Avenue, Suite 800,
Seattle, Washington 98121
United States,
(206)728-5090
www.coruspharma.com

Corus Pharma is committed to developing and commercializing specialty products for respiratory and infectious diseases that can help provide improved health and superior quality of life.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.